Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Sell
43
FONR Quote, Financials, Valuation and Earnings
Last price:
$14.19
Seasonality move
:
0.99%
Day range:
$13.00 - $13.73
52-week range:
$12.00 - $18.68
Dividend yield:
0%
P/E ratio:
10.81x
P/S ratio:
0.83x
P/B ratio:
0.49x
Volume:
76K
Avg. volume:
21.9K
1-year change:
-11.35%
Market cap:
$85.1M
Revenue:
$102.9M
EPS (TTM):
$1.25
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Fonar has -- downside to fair value with a price target of -- per share.
FONR vs. S&P 500
-
Over the past 5 trading days, Fonar has overperformed the S&P 500 by 7.92% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Fonar does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Fonar has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Fonar reported revenues of $27.2M.
Earnings Growth
-
Fonar has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Fonar reported earnings per share of $0.37.
Enterprise value:
19.1M
EV / Invested capital:
0.12x
Price / LTM sales:
0.83x
EV / EBIT:
1.33x
EV / Revenue:
0.19x
PEG ratio (5yr expected):
0.71x
EV / Free cash flow:
2.37x
Price / Operating cash flow:
10.68x
Enterprise value / EBITDA:
0.82x
Gross Profit (TTM):
$42.5M
Return On Assets:
3.98%
Net Income Margin (TTM):
8.19%
Return On Equity:
5.33%
Return On Invested Capital:
5.32%
Operating Margin:
13.48%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $97.7M | $102.7M | $103M | $25.7M | $27.2M | |
| Gross Profit | $45.6M | $46.8M | $42.5M | $11.8M | $12.1M | |
| Operating Income | $16.5M | $17.7M | $12M | $3.7M | $3.7M | |
| EBITDA | $25.8M | $26M | $23.2M | $5.5M | $5.4M | |
| Diluted EPS | $1.48 | $1.56 | $1.25 | $0.27 | $0.37 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $103.6M | $114.3M | $122M | $135.8M | $141.1M | |
| Total Assets | $185.3M | $195.6M | $199.3M | $209.6M | $214.9M | |
| Current Liabilities | $17.1M | $14.2M | $13.9M | $14.5M | $14M | |
| Total Liabilities | $50.5M | $51.4M | $48.7M | $52.6M | $54.7M | |
| Total Equity | $134.8M | $144.3M | $150.6M | $157M | $160.3M | |
| Total Debt | $963K | $209K | $169K | $126K | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $15.3M | $13.8M | $11.6M | $2.8M | $3.1M | |
| Cash From Investing | -$4.4M | -$1.2M | -$3.5M | -$289K | -$600K | |
| Cash From Financing | -$7.3M | -$8.3M | -$7.9M | -$1.8M | -$1.9M | |
| Free Cash Flow | $10.9M | $12.7M | $8M | $2.6M | $2.5M | |
FONR
Sector
Market Cap
$85.1M
$34.2M
Price % of 52-Week High
72.32%
43.73%
Dividend Yield
0%
0%
Shareholder Yield
2.78%
-0.66%
1-Year Price Total Return
-11.35%
-41.71%
Beta (5-Year)
1.003
0.657
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$12.71
200-day SMA
Sell
Level
$15.20
Bollinger Bands (100)
Sell
Level
12.79 - 15.49
Chaikin Money Flow
Sell
Level
-67.8M
20-day SMA
Buy
Level
$12.43
Relative Strength Index (RSI14)
Buy
Level
61.47
ADX Line
Buy
Level
22.32
Williams %R
Sell
Level
-17.4699
50-day SMA
Buy
Level
$12.96
MACD (12, 26)
Buy
Level
0.03
25-day Aroon Oscillator
Buy
Level
56
On Balance Volume
Neutral
Level
28.2M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.4537)
Buy
CA Score
(Annual)
Level (1.4387)
Buy
Beneish M-Score
(Annual)
Level (-2.4259)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.9879)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.
Stock Forecast FAQ
In the current month, FONR has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The FONR average analyst price target in the past 3 months is --.
-
Where Will Fonar Stock Be In 1 Year?
According to analysts, the consensus estimate is that Fonar share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Fonar?
Analysts are divided on their view about Fonar share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Fonar is a Sell and believe this share price will rise from its current level to --.
-
What Is Fonar's Price Target?
The price target for Fonar over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is FONR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Fonar is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of FONR?
You can purchase shares of Fonar via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Fonar shares.
-
What Is The Fonar Share Price Today?
Fonar was last trading at $14.19 per share. This represents the most recent stock quote for Fonar. Yesterday, Fonar closed at $13.51 per share.
-
How To Buy Fonar Stock Online?
In order to purchase Fonar stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
99
SOC alert for May 20
Sable Offshore [SOC] is down 0.79% over the past day.
Buy
52
RGC alert for May 20
Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.
Sell
40
GWLIF alert for May 20
Great-West Lifeco [GWLIF] is up 13.42% over the past day.
